Becton Dickinson (BDX) financials
Becton Dickinson revenue and earnings by year
Becton Dickinson's revenue was $21.8 billion in the fiscal year to September 30, 2025, up 8.2% from the year before. Net income was $1.68 billion, 7.7% of revenue. Since the fiscal year to September 30, 2016, revenue has grown 6.4% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.8 | 20.2 | 19.4 | 18.9 | 19.1 | 16.1 | 17.3 | 16.0 | 12.1 | 12.5 |
| Revenue growth | 8.2% | 4.2% | 2.7% | -1.4% | 19.0% | -7.0% | 8.2% | 32.2% | -3.1% | — |
| Gross profit | 9.9 | 9.1 | 8.2 | 8.5 | 8.6 | 6.8 | 8.3 | 7.3 | 6.0 | 6.0 |
| Gross margin | 45.4% | 45.2% | 42.2% | 44.9% | 45.1% | 42.3% | 47.9% | 45.5% | 49.3% | 48.0% |
| Operating income | 2.6 | 2.4 | 2.1 | 2.3 | 2.3 | 0.9 | 1.8 | 1.5 | 1.5 | 1.4 |
| Operating margin | 11.8% | 11.9% | 10.9% | 12.1% | 11.8% | 5.7% | 10.2% | 9.4% | 12.6% | 11.5% |
| Net income | 1.7 | 1.7 | 1.5 | 1.8 | 2.1 | 0.9 | 1.2 | 0.3 | 1.1 | 1.0 |
| Net margin | 7.7% | 8.4% | 7.7% | 9.4% | 10.9% | 5.4% | 7.1% | 1.9% | 9.1% | 7.8% |
| Diluted EPS | $4.58 | $4.61 | $3.88 | $4.62 | $5.25 | $2.09 | $3.02 | $0.34 | $3.57 | $3.46 |
| Free cash flow | 2.7 | 3.1 | 2.1 | 1.7 | 3.5 | 2.8 | 2.4 | 2.0 | 1.8 | 1.9 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open BDX in Markets.
How Becton Dickinson makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Medical Essentials | $1.68B | 33.6% |
| Interventional | $1.41B | 28.4% |
| Connected Care | $1.22B | 24.6% |
| Bio Pharma Systems | $670M | 13.4% |
See also: BDX valuation and P/E history · BDX returns
No forecast, no recommendation. This page describes Becton Dickinson from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.